[ad_1] United Airlines Holdings, Inc. (NYSE: UAL) is expected to publish first-quarter results today, after the closing bell, amid expectations for a mixed outcome. Listen to United Airlines‘ earnings call live and check the real-time transcript Wall Street will be looking for a loss per share of $0.57 for Q1, on an adjusted basis. The estimate represents an improvement from the year-ago quarter when the company incurred a loss of $0.63 per share. Analysts predict an 8.9% increase in revenues to $12.45 billion for the March quarter. United’s quarterly profit has topped expectations consistently for over a year after the bottom…
Author: Sanjayananda
[ad_1] Over the last several days, market observers have been perplexed by the lack of a bullish reaction within oil markets after Iran’s attack on Israel over the weekend. Let’s reset the backdrop on the oil markets to get a better perspective on the price action.Crude oil has been in a solid uptrend that started in the middle of December last year. Managed money funds held a substantial net short futures positions as industry data reflected supply gluts in crude inventories as well as byproducts like gasoline. However, these supply gluts were intentional; oil companies were leveraging refining rates to build…
[ad_1] On-chain data shows the next major Bitcoin demand zone is around $56,000, a level BTC might end up revisiting if the decline continues. Bitcoin Has Next Major On-Chain Support Around $56,000 According to data from the market intelligence platform IntoTheBlock, BTC’s recent drawdown has meant that it may end up having to rely on the price range around $56,000 for support. In on-chain analysis, a level’s potential as support or resistance is based on the total number of coins that the investors last acquired there. Below is a chart that shows what the various price ranges around the current…
[ad_1] Image source: Getty Images One of the main reasons I buy FTSE shares is to create a second income stream through dividend stocks. Let me explain a simple approach I would take if I could. Furthermore, I’ll break down one stock that could help me achieve my aims. My method Firstly, I’d set aside £300 per month. Next, I need to decide on an investment vehicle. I could go down the individual stocks route, but I’d be liable to pay capital gains and dividend tax. The better option is a Stocks and Shares ISA, in my view. This is…
[ad_1] Good Morning Traders! In today’s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market’s pulse to optimize your trading gains. Now, let’s dive into…
[ad_1] Image source: Getty Images Many years ago my parents tried to warn me that fizzy drinks could rot my teeth. They didn’t teach me that buying shares in FTSE 100 incumbent Coca-Cola Hellenic Bottling Company (LSE: CCH) could be a sweet investment. Here’s why I believe investors should be taking a closer look at the stock. Bottling fizz As the name suggests, Coca-Cola HBC – as it is best known – is the bottling subsidiary of the drinks giant. Based in Europe, it bottles famous fizzy drinks including Coca-Cola, Fanta, and Sprite to name a few. It then sells…
[ad_1] M&T Bank Corporation MTB reported in-line first-quarter earnings on Monday.Revenue of $2.260 billion, slightly missing the consensus of $2.263 billion. Net income of $531 million came below $702 million a year ago. EPS was $3.09, which came in line with the consensus, according to data from Benzinga Pro.M&T held total assets of $211.5 billion as of March 31, 2024. Loans and leases, net of unearned discount, were $133.8 billion. The CET1 capital ratio was estimated at 11.07% as of March 31, 2024.Daryl N. Bible, M&T’s Chief Financial Officer, said,“We are off to a solid start in 2024 as we…
[ad_1] Arbitrum (ARB) runs the risk of a significant price decline due to its upcoming token unlock on April 16. These token unlock events are known to be a recipe for high volatility because of what could happen in the aftermath of their occurrence. $107 Million Arbitrum Tokens Set To Be Unlocked Data from TokenUnlock shows that 92.65 million Arbitrum tokens (3.49% of its circulating supply) are set to be unlocked on April 16. 56.13 million ($65.10 million) of these tokens will be distributed to the team, future team, and advisors, while the remaining 36.52 million ($42.36 million) will be…
[ad_1] The PNC Financial Services Group, Inc. (NYSE: PNC) on Tuesday reported a decrease in revenues and net profit for the first quarter of 2024. Net income attributable to common shareholders declined to $1.34 billion or $3.10 per share in the March quarter from $1.69 billion or $3.89 per share in the comparable period of 2023. On an adjusted basis, earnings dropped to $3.36 per share in Q1 from $3.98 per share last year. Revenues declined 8% annually to $5.15 billion during the three months, reflecting year-over-year decreases in both net interest income and non-interest income. Prior Performance [ad_2] Source…
[ad_1] AstraZeneca Plc AZN released updated exploratory results from the TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in combination with standard-of-care chemotherapy for advanced biliary tract cancer (BTC).The data showed that Imfinzi plus standard-of-care chemotherapy demonstrated a clinically meaningful long-term overall survival (OS) benefit in advanced biliary tract cancer patients at three years.The company says the TOPAZ-1 results are the longest survival follow-up ever reported for a global, randomized Phase 3 trial in this setting.Related: New Hope for Aggressive Lung Cancer: AstraZeneca’s Imfinzi Shows Promising Results in Phase 3 Trial.At more than three years (median follow-up of 41.3 months), results showed that Imfinzi plus chemotherapy reduced the risk of death…